Cargando…
Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach
Pancreatic cancer is the leading cause of death from solid malignancies worldwide. Currently, gemcitabine is the only drug approved for treating pancreatic cancer. Developing new therapeutic drugs for this disease is, therefore, an urgent need. The C-Map project has provided a wealth of gene express...
Autores principales: | Ma, Yanfen, Hu, Jian, Zhang, Ning, Dong, Xinran, Li, Ying, Yang, Bo, Tian, Weidong, Wang, Xiaoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765895/ https://www.ncbi.nlm.nih.gov/pubmed/26910401 http://dx.doi.org/10.1371/journal.pone.0149896 |
Ejemplares similares
-
The synergistic bactericidal effect of vancomycin on UTMD treated biofilm involves damage to bacterial cells and enhancement of metabolic activities
por: Hu, Jian, et al.
Publicado: (2018) -
The identification of candidate effective combination regimens for pancreatic cancer using the histoculture drug response assay
por: Jun, Eunsung, et al.
Publicado: (2020) -
Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
por: Wang, Xiuchao, et al.
Publicado: (2022) -
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
por: Veschi, Serena, et al.
Publicado: (2018) -
Molecular Mechanisms and Function Prediction of Long Noncoding RNA
por: Ma, Handong, et al.
Publicado: (2012)